|
MADISON, WI — August 7, 2006 — NimbleGen Systems, the leading supplier of flexible, high-density DNA microarrays used in the fastest growing markets for genome research, has named David S. Snyder as Chief Financial Officer.
“NimbleGen’s products achieved remarkable traction in the marketplace last year,” said Mr. Snyder. “I’m looking forward to applying my experience in building and managing large, entrepreneurial growth companies to the extraordinary technological platform the NimbleGen team has created.”
Snyder has over 15 years of experience as a CFO in rapidly growing companies, with one such firm growing to nearly $2 billion in revenue and another growing to nearly $3 billion in assets. He’s served as CFO for two publicly traded companies and brings extensive experience in capital raising, finance and general management. His experience spans industries ranging from technology to real estate to diversified manufacturing. In addition to his experience as CFO, Snyder has held positions of corporate strategy and business unit operations. Snyder graduated from the Harvard Business School with high honors and was designated a Baker Scholar. He received his BA from Ottawa University.
“We’re absolutely delighted to have someone of David’s caliber join the NimbleGen team,“ said NimbleGen’s President and CEO, Dr. Stan Rose. “David brings a wealth of experience with successful entrepreneurial companies, both private and public, along with a solid knowledge of Wall Street. He will play a key role in developing and implementing our financial plans going forward, ensuring we have access to the resources we need to continue to fuel our growth.”
About NimbleGen Systems, Inc.
NimbleGen Systems, the leading supplier of flexible high-density microarray products and services, is enabling a new era of High-Definition Genomics. NimbleGen uniquely produces high-density arrays of isothermal long oligos that provide superior results for advanced genomic analysis methods such as CGH, ChIP, microbial Comparative Genome Sequencing, and expression tiling. NimbleGen's High-Definition Genomics enables scientists to obtain and integrate complex genomic data sets not previously accessible, providing a much clearer understanding of genome structure and function, and how this relates to biology and medicine. This improved performance is made possible by NimbleGen's Maskless Array Synthesis (MAS) technology, which uses digital light processing and rapid, high-yield photochemistry to synthesize high-density DNA microarrays.
|
